[Federal Register Volume 85, Number 173 (Friday, September 4, 2020)]
[Notices]
[Pages 55264-55265]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19678]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Meeting

AGENCY: Under Secretary of Defense for Personnel and Readiness, 
Department of Defense (DoD).

ACTION: Notice of Federal Advisory Committee meeting.

-----------------------------------------------------------------------

SUMMARY: The DoD is publishing this notice to announce the following 
Federal Advisory Committee meeting of the Uniform Formulary Beneficiary 
Advisory Panel will take place.

DATES: Open to the public Wednesday, September 23, 2020, from 12:00 
p.m. to 6:00 p.m. (Eastern Daylight Time).

ADDRESSES: The open meeting will be held online. The phone number for 
remote access is CONUS: 888-469-2037; OCONUS: 1-517-308-9287; 
PARTICIPANT CODE: 8227323. These numbers and the dial-in instructions 
will also be posted on the Uniform Formulary Beneficiary Advisory Panel 
website at: https://www.health.mil/About-MHS/OASDHA/Defense-Health-Agency/Operations/Pharmacy-Division/Beneficiary-Advisory-Panel.

FOR FURTHER INFORMATION CONTACT: Colonel Paul J. Hoerner, USAF, 703-
681-2890 (Voice), [email protected] (Email). Mailing 
address is 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 
22042-5101. Website: https://www.health.mil/About-MHS/OASDHA/Defense-Health-Agency/Operations/Pharmacy-Division/Beneficiary-Advisory-Panel. 
The most up-to-date changes to the meeting agenda can be found on the 
website.

SUPPLEMENTARY INFORMATION: This meeting is being held under the 
provisions of the Federal Advisory Committee Act (FACA) (5 U.S.C., 
Appendix), the Government in the Sunshine Act (5 U.S.C. 552b), and 41 
CFR 102-3.140 and 102-3.150.
    The Panel will review and comment on recommendations made to the 
Director, Defense Health Agency, by the Pharmacy and Therapeutics 
Committee, regarding the Uniform Formulary.
    Purpose of the Meeting: The DoD is publishing this notice to 
announce that the following Federal Advisory Committee meeting of the 
Uniform Formulary Beneficiary Advisory Panel will take place.

Agenda

1. Sign-In
2. Welcome and Opening Remarks
3. Scheduled Therapeutic Class Reviews (Comments will follow each 
agenda item)
    a. Psoriasis Agents--NA
    b. Sleep Disorders--Wakefulness Promoting Agents
    c. White Blood Cell Stimulants--Filgrastims
    d. White Blood Cell Stimulants--Pegfilgrastims

[[Page 55265]]

4. Newly-Approved Drugs Review
5. Pertinent Utilization Management Issues
6. Panel Discussions and Vote
    Meeting Accessibility: Pursuant to 5 U.S.C. 552b, and 41 CFR 102-
3.140 through 102-3.165, and the subject to availability of phone 
lines, this meeting is open to the public. Seating is limited and will 
be provided only to the first 220 people dialing in. There will be 220 
lines total: 200 domestic and 20 international, including leader lines.
    Written Statements: Pursuant to 41 CFR 102-3.10, and section 
10(a)(3) of FACA, interested persons or organizations may submit 
written statements to the Uniform Formulary Beneficiary Advisory Panel 
about its mission and/or the agenda to be addressed in this public 
meeting. Written statements should be submitted to the Uniform 
Formulary Beneficiary Advisory Panel's Designated Federal Officer 
(DFO). The DFO's contact information can be found in the FOR FURTHER 
INFORMATION CONTACT section of this notice. Written comments or 
statements must be received by the Uniform Formulary Beneficiary 
Advisory Panel's DFO at least five (5) business days prior to the 
meeting so they may be made available to the Uniform Formulary 
Beneficiary Advisory Panel for its consideration prior to the meeting. 
The DFO will review all submitted written statements and provide copies 
to all Uniform Formulary Beneficiary Advisory Panel members.

    Dated: September 1, 2020.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2020-19678 Filed 9-3-20; 8:45 am]
BILLING CODE 5001-06-P